BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28217945)

  • 1. Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?
    Wenink MH; Leijten EFA; Cupedo T; Radstake TRDJ
    Arthritis Rheumatol; 2017 May; 69(5):885-897. PubMed ID: 28217945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunology of rheumatoid diseases.
    Koffler D
    Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases].
    Fabregas-Canales D; Meyer O; Haim T; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunology and rheumatic diseases. History and current aspects].
    Bonomo L
    Recenti Prog Med; 1976 Dec; 61(6):741-8. PubMed ID: 1088188
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the laboratory in rheumatology. Lymphocytes.
    Russell AS; Edelman J
    Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
    Aleksandrova EN; Zimin IuI; Nasonov EL
    Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field].
    Biddau A; Bartoletti L; Doni A
    Reumatismo; 1968; 20(5):545-9. PubMed ID: 4186692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histocompatability antigens in rheumatic diseases].
    Tannenbaum H
    Union Med Can; 1976 Apr; 105(4):581-4. PubMed ID: 793131
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases.
    Bank I
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our current experience in the detection of serum rheumatoid factors by immunofluorescence].
    Eshougues JR; Biserte G; Delcambre B; Leonardelli J; Flamencourt P
    Rev Rhum Mal Osteoartic; 1973; 40(7):491-6. PubMed ID: 4585619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study.
    MacSween RN; Goudie RB; Anderson JR; Armstrong E; Murray MA; Mason DK; Jasani MK; Boyle JA; Buchanan WW; Williamson J
    Ann Rheum Dis; 1967 Sep; 26(5):402-11. PubMed ID: 5341916
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inflammatory rheumatism within the framework of autoimmune diseases].
    Van Slype J
    J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
    [No Abstract]   [Full Text] [Related]  

  • 17. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
    Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free CD5 in patients with rheumatic diseases.
    Jamin C; Magadur G; Lamour A; Mackenzie L; Lydyard P; Katsikis P; Youinou P
    Immunol Lett; 1992 Jan; 31(1):79-83. PubMed ID: 1372282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.